Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 28 ... Plumb, President and CEO of Inhibitex, Inc. "We continue to anticipate completing our PhaseII clinical trial of FV-100 in shingles patients around the middle of next year, and ...
2009 NOV 23 ... between LVEF and SRS (r=-0.31, P<.0001) and there were stronger correlations between phase SD and SRS (r=0.66, P<.0001) as well as phase SD and LVEF (r=-0.50, P<.0001). with ... versus usual care in 2,331 stable patients with LVEF of <= 35% and NYHA class II to IV HF symptoms treated with optimal medical therapy. enrolled in the HF-ACTION ... unknown." "This article addresses the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION) gated SPECT imaging (gSPECT) ...
2009 NOV 23 ... fallopian tube cancer, or primary peritoneal cancer were eligible for enrolment in this phase 3, open-label, randomised controlled trial at 85 centres in Japan. were randomly ... a dose-dense weekly regimen in women with advanced ovarian cancer. Patients with stage II to IV epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer ...
2009 NOV 23 ... Novavax, Inc. (NASDAQ: NVAX) has begun a Phase IIa clinical study of its trivalent seasonal influenza VLP vaccine candidate in healthy ... President and Chief Executive Officer of Novavax. "Recall that in a recent Phase II study in healthy adults ranging in ages from 18-49 years, we showed that our seasonal ... allow us to select a dose for a future Phase IIb confirmatory, non-inferiority clinical trial in this population. Moreover, it will also give us a clear signal of how our seasonal ...
2009 NOV 23 ... Rolapitant, a neurokinin-1 (NK-1) receptor antagonist, recently completed PhaseII clinical testing for prevention of nausea and vomiting related to cancer chemotherapy ... Health, Clinical Trials, Pharmaceutical, General Health, Cancer, Chemotherapy, Clinical Trial Research, Drug Therapy, Merck & Company Inc., Nausea, Oncology, Pharmaceutical Business, ...
2009 NOV 23 ... HIV," investigators in Tourcoing, France report. "enrolled in this phaseII, noncomparative, multicenter trial were naive to the investigational drugs and had ...
2009 NOV 23 ... Typhi. Several clinical trials have been completed for the vaccine, including large phaseII trials in the US and Vietnam. Additionally, a phase IIc clinical trial was ongoing in ...
2009 NOV 23 ... to a study from People's Republic of China, "2-Methoxyestradiol is currently in phaseII clinical trials as a chemotherapeutic agent. An LC method with fluorescence detection ... Keywords: Country:People's Republic of China, Biotechnology, Chromatography, Clinical Trial Research, Diagnosis, Diagnostics, Drugs, Infectious Disease, Pharmaceuticals, ...
2009 NOV 23 ... "Mature results are presented from a phase II trial of postoperative concurrent chemoradiotherapy in patients with poor-prognosis cancer of ...
2009 NOV 23 ... New research, 'PhaseII study of gemcitabine monotherapy as a salvage treatment for Japanese metastatic ... Antineoplastic, Antiviral, Breast Cancer, Breast Carcinoma, Clinical Oncology, Clinical Trial Research, Gemcitabine, Immunosuppressant, Oncology, Radiation-Sensitizing Agent, ...
2009 NOV 23 ... after immunotherapy including dendritic cell (DC) vaccination. In a recently published phase I/II trials, fourteen HLA-A2 negative patients with progressive mRCC were vaccinated ... MA 02148, USA. Keywords: Denmark, Biotechnology, Cancer Vaccines, Clinical Trial Research, Gastroenterology, Immunization, Immunology, Immunotherapy, Kidney, Nephrology, ...
2009 NOV 23 ... phase I trial in healthy adults, VCL-CB01 was well tolerated. In interim results from a phase II trial in hCMV-seropositive hematopoietic cell transplant recipients, VCL-CB01 increased T-cell ...
2009 NOV 23 ... DER45-EV Gel for the topical treatment of rosacea. This IND allows Sol-Gel to initiate PhaseII studies with DER45-EV Gel in rosacea patients. DER45-EV Gel is an ... Other Heal, Food, Science & Technology, Technology, Biotechnology, Clinical Trial Research, Drug Delivery, Drug Development, FDA, Regulatory Actions, Rosacea, Therapy, ...
2009 NOV 23 ... "Praneem', a polyherbal formulation developed by us, has successfully completed PhaseII efficacy study for treatment of abnormal vaginal discharge due to reproductive tract ... Country:India, Cervical Cancer, Cervical Carcinoma, Clinical Oncology, Clinical Trial Research, Gynecology, HPV, Human Papillomavirus, Inflammation, Menstruation, Oncology, ...
2009 NOV 23 ... "The Radiation Therapy Oncology Group (RTOG) embarked on a phase I/II study of patients suffering from glioblastoma multiforme (protocol 98-03) to assess ... impact on life quality and neurocognition can be carried out in a large international trial. Baseline SQLI is a statistically significant determinant of survival," wrote B.W. Corn ...
2009 NOV 23 ... as potentially painful surgical interventions." Currently in a 75-patient PhaseII diabetic foot ulcer clinical trial being conducted at some of the nation's top ...
2009 NOV 23 ... events; all AEs resolved by the end of both studies. "The results from these two PhaseII studies provide further basis for the continued development of TBR-652 for the ... development programs. We look forward to the results from our on-going proof of concept trial of TBR-652." These data were presented at the 12th European AIDS ...
2009 NOV 23 ... of the Research Center at the Montreal Heart Institute, will present data from a Phase IIa clinical trial evaluating VT-111 at the American Heart Association (AHA) Scientific ...
2009 NOV 23 ... Oncology Society (CTOS) Meeting, positive interim data from the multicenter randomized Phase II trial of palifosfamide (ZymafosTM, ZIO-201) treating patients with unresectable or metastatic ...
2009 NOV 23 ... programs have progressed well. The palifosfamide (ZymafosTM, ZIO-201) randomized Phase II trial in metastatic or unresectable soft tissue sarcoma achieved the study-specified efficacy ...
